Review



recombinant human pd 1 protein  (Sino Biological)


Bioz Verified Symbol Sino Biological is a verified supplier
Bioz Manufacturer Symbol Sino Biological manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Sino Biological recombinant human pd 1 protein
    Recombinant Human Pd 1 Protein, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 31 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+pd+1+protein/Human+PD-1+Protein/pm41989091-31-0-10
    Average 94 stars, based on 31 article reviews
    recombinant human pd 1 protein - by Bioz Stars, 2026-11
    94/100 stars

    Images

    Related Articles

    Blocking Assay:

    Article Title: Humanized anti-PD-1 antibody and the use thereof
    Article Snippet: .. This result indicates that the murine antibody PD1-M944 has a good function of blocking the binding of PD-1 to its ligand PD-L1. (2) Blocking the Binding of Recombinant Human PD-1 to PD-L2: Recombinant human PD-1 protein at a concentration of 1 μg/mL was coated on a 96-well plate at 100 μL per well, overnight at 4° C., overnight, washed the next day and blocked at room temperature for 1 h. 100 μL of 0.5 μg/mL of biotinylated protein PD-L2-Fc-biotin (Sino Biological, Inc.) was co-incubated with different concentrations (0.5 μg/mL, 2.5 μg/mL and 12.5 μg/mL) of PD1-M944 or Nivolumab (Sino Biological, Inc.). .. The plates were washed to remove unbound antibodies, incubated with antibiotic streptavidin/HRP (Beijing Zhong Shan-Golden Bridge Biological Technology Co., Ltd), repeatedly washed, and the substrate chromogenic solution was added for color development, and OD450 was detected after termination.

    Article Title: Humanized anti-PD-1 antibody and the use thereof
    Article Snippet: .. 1.4 Murine Antibody PD1-M944 Functional Assay (1) Blocking the Binding of Recombinant Human PD-1 to PD-L1: Recombinant human PD-1 protein at a concentration of 1 μg/mL was coated on a 96-well plate at 100 μL per well overnight at 4° C. The plates were washed the next day and blocked at room temperature for 1 h. 100 μL of 10 μg/mL of biotinylated protein PD-L1-Fc-biotin (SinoBiological, Inc.) was co-incubated with different concentrations (0.4 μg/mL, 2 μg/mL and 10 μg/mL) of PD1-M944 or Nivolumab (Sino Biological, Inc). ..

    Binding Assay:

    Article Title: Humanized anti-PD-1 antibody and the use thereof
    Article Snippet: .. This result indicates that the murine antibody PD1-M944 has a good function of blocking the binding of PD-1 to its ligand PD-L1. (2) Blocking the Binding of Recombinant Human PD-1 to PD-L2: Recombinant human PD-1 protein at a concentration of 1 μg/mL was coated on a 96-well plate at 100 μL per well, overnight at 4° C., overnight, washed the next day and blocked at room temperature for 1 h. 100 μL of 0.5 μg/mL of biotinylated protein PD-L2-Fc-biotin (Sino Biological, Inc.) was co-incubated with different concentrations (0.5 μg/mL, 2.5 μg/mL and 12.5 μg/mL) of PD1-M944 or Nivolumab (Sino Biological, Inc.). .. The plates were washed to remove unbound antibodies, incubated with antibiotic streptavidin/HRP (Beijing Zhong Shan-Golden Bridge Biological Technology Co., Ltd), repeatedly washed, and the substrate chromogenic solution was added for color development, and OD450 was detected after termination.

    Article Title: Humanized anti-PD-1 antibody and the use thereof
    Article Snippet: .. 1.4 Murine Antibody PD1-M944 Functional Assay (1) Blocking the Binding of Recombinant Human PD-1 to PD-L1: Recombinant human PD-1 protein at a concentration of 1 μg/mL was coated on a 96-well plate at 100 μL per well overnight at 4° C. The plates were washed the next day and blocked at room temperature for 1 h. 100 μL of 10 μg/mL of biotinylated protein PD-L1-Fc-biotin (SinoBiological, Inc.) was co-incubated with different concentrations (0.4 μg/mL, 2 μg/mL and 10 μg/mL) of PD1-M944 or Nivolumab (Sino Biological, Inc). ..

    Recombinant:

    Article Title: Humanized anti-PD-1 antibody and the use thereof
    Article Snippet: .. This result indicates that the murine antibody PD1-M944 has a good function of blocking the binding of PD-1 to its ligand PD-L1. (2) Blocking the Binding of Recombinant Human PD-1 to PD-L2: Recombinant human PD-1 protein at a concentration of 1 μg/mL was coated on a 96-well plate at 100 μL per well, overnight at 4° C., overnight, washed the next day and blocked at room temperature for 1 h. 100 μL of 0.5 μg/mL of biotinylated protein PD-L2-Fc-biotin (Sino Biological, Inc.) was co-incubated with different concentrations (0.5 μg/mL, 2.5 μg/mL and 12.5 μg/mL) of PD1-M944 or Nivolumab (Sino Biological, Inc.). .. The plates were washed to remove unbound antibodies, incubated with antibiotic streptavidin/HRP (Beijing Zhong Shan-Golden Bridge Biological Technology Co., Ltd), repeatedly washed, and the substrate chromogenic solution was added for color development, and OD450 was detected after termination.

    Article Title: Engineering affibody domains as anti-idiotypic masks for nivolumab-based prodrugs
    Article Snippet: Protein concentrations were measured by absorbance at 280 nm using a spectrophotometer (Thermo Fisher, USA). .. Recombinant Human PD-1 Protein (ECD, His Tag) was purchased from Sino Biological (China), and recombinant tobacco etch virus (TEV) protease was produced and purified in-house following standard methods. .. E. coli BL21 (DE3) cells transformed with pPALU ( ) plasmids encoding for an affibody library (~10 11 variants) were grown overnight (O/N) in Luria-Bertani (LB) medium supplemented with carbenicillin (100 μg/ml).

    Article Title: Engineering affibody domains as anti-idiotypic masks for nivolumab-based prodrugs.
    Article Snippet: Protein concentrations were measured by absorbance at 280 nm using a spectrophotometer (Thermo Fisher, USA). .. Recombinant Human PD-1 Protein (ECD, His Tag) was purchased from Sino Biological (China), and recombinant tobacco etch virus (TEV) protease was produced and purified inhouse following standard methods. .. D ow nloaded from https://academ ic.oup.com /peds/advance-article/doi/10.1093/protein/gzag010/8655119 by guest on 18 April 2026 UN CO RR EC TE D MA NU SC RI PT Bacterial culture and library expression Escherichia coli BL21 (DE3) cells transformed with pPALU9 plasmids encoding for an affibody library (~1011 variants) were grown overnight (O/N) in Luria-Bertani (LB) medium supplemented with carbenicillin (100 μg/mL).

    Article Title: Tumor-Specific Delivery of Immune Checkpoint Inhibitors by Engineered AAV Vectors
    Article Snippet: .. For the detection of AAV-encoded nivolumab, plate coating was performed with 100 ng/well using recombinant human PD-1 protein (Sino Biological) in H 2 O overnight, while the remaining procedure was identical, only varying in secondary antibody concentration and incubation time (αhuFc-HRP 1:10,000 for 3 h and 1:500 for 2 h for murine αPD-1 and AAV-Nivolumab, respectively). .. Standard values were generated using the therapeutic drug Opdivo® (Bristol Myers Squibb).

    Article Title: Humanized anti-PD-1 antibody and the use thereof
    Article Snippet: .. 1.4 Murine Antibody PD1-M944 Functional Assay (1) Blocking the Binding of Recombinant Human PD-1 to PD-L1: Recombinant human PD-1 protein at a concentration of 1 μg/mL was coated on a 96-well plate at 100 μL per well overnight at 4° C. The plates were washed the next day and blocked at room temperature for 1 h. 100 μL of 10 μg/mL of biotinylated protein PD-L1-Fc-biotin (SinoBiological, Inc.) was co-incubated with different concentrations (0.4 μg/mL, 2 μg/mL and 10 μg/mL) of PD1-M944 or Nivolumab (Sino Biological, Inc). ..

    Article Title: PD-L1 targeted peptide demonstrates potent antitumor and immunomodulatory activity in cancer immunotherapy
    Article Snippet: .. Human PD-L1 natural ORF mammalian expression plasmid (Cat: HG10084-UT), rabbit anti-human PD-1 antibody (Clone D67, Cat: 10377-RD67), recombinant human PD-L1 protein (Cat: 10084-H08H), human PD-L1/B7-H1/CD274 protein (Cat: 10084-HNAH), biotinylated mouse PD-1/PDCD1 protein (His tag) and recombinant human PD-1 protein (Cat: 10377-H08H) were purchased from Sino Biological Inc (Beijing). .. GM-CSF (Cat: 315-03) and Murine TNF-α (Cat: 315-01A) were purchased from PEPROTECH.

    Article Title: Discovery of galectin-8 as an LILRB4 ligand driving M-MDSCs defines a class of antibodies to fight solid tumors
    Article Snippet: Recombinant human LY86 protein (ECD, hFc Tag) , Sino Biological , Cat#10242-H02H. .. Recombinant human PD-1 protein (ECD, hFc Tag) , Sino Biological , Cat#10377-H02. .. Recombinant human CD8b protein (ECD, hFc Tag) , Sino Biological , Cat#11031-HCCH.

    Concentration Assay:

    Article Title: Humanized anti-PD-1 antibody and the use thereof
    Article Snippet: .. This result indicates that the murine antibody PD1-M944 has a good function of blocking the binding of PD-1 to its ligand PD-L1. (2) Blocking the Binding of Recombinant Human PD-1 to PD-L2: Recombinant human PD-1 protein at a concentration of 1 μg/mL was coated on a 96-well plate at 100 μL per well, overnight at 4° C., overnight, washed the next day and blocked at room temperature for 1 h. 100 μL of 0.5 μg/mL of biotinylated protein PD-L2-Fc-biotin (Sino Biological, Inc.) was co-incubated with different concentrations (0.5 μg/mL, 2.5 μg/mL and 12.5 μg/mL) of PD1-M944 or Nivolumab (Sino Biological, Inc.). .. The plates were washed to remove unbound antibodies, incubated with antibiotic streptavidin/HRP (Beijing Zhong Shan-Golden Bridge Biological Technology Co., Ltd), repeatedly washed, and the substrate chromogenic solution was added for color development, and OD450 was detected after termination.

    Article Title: Tumor-Specific Delivery of Immune Checkpoint Inhibitors by Engineered AAV Vectors
    Article Snippet: .. For the detection of AAV-encoded nivolumab, plate coating was performed with 100 ng/well using recombinant human PD-1 protein (Sino Biological) in H 2 O overnight, while the remaining procedure was identical, only varying in secondary antibody concentration and incubation time (αhuFc-HRP 1:10,000 for 3 h and 1:500 for 2 h for murine αPD-1 and AAV-Nivolumab, respectively). .. Standard values were generated using the therapeutic drug Opdivo® (Bristol Myers Squibb).

    Article Title: Humanized anti-PD-1 antibody and the use thereof
    Article Snippet: .. 1.4 Murine Antibody PD1-M944 Functional Assay (1) Blocking the Binding of Recombinant Human PD-1 to PD-L1: Recombinant human PD-1 protein at a concentration of 1 μg/mL was coated on a 96-well plate at 100 μL per well overnight at 4° C. The plates were washed the next day and blocked at room temperature for 1 h. 100 μL of 10 μg/mL of biotinylated protein PD-L1-Fc-biotin (SinoBiological, Inc.) was co-incubated with different concentrations (0.4 μg/mL, 2 μg/mL and 10 μg/mL) of PD1-M944 or Nivolumab (Sino Biological, Inc). ..

    Virus:

    Article Title: Engineering affibody domains as anti-idiotypic masks for nivolumab-based prodrugs
    Article Snippet: Protein concentrations were measured by absorbance at 280 nm using a spectrophotometer (Thermo Fisher, USA). .. Recombinant Human PD-1 Protein (ECD, His Tag) was purchased from Sino Biological (China), and recombinant tobacco etch virus (TEV) protease was produced and purified in-house following standard methods. .. E. coli BL21 (DE3) cells transformed with pPALU ( ) plasmids encoding for an affibody library (~10 11 variants) were grown overnight (O/N) in Luria-Bertani (LB) medium supplemented with carbenicillin (100 μg/ml).

    Article Title: Engineering affibody domains as anti-idiotypic masks for nivolumab-based prodrugs.
    Article Snippet: Protein concentrations were measured by absorbance at 280 nm using a spectrophotometer (Thermo Fisher, USA). .. Recombinant Human PD-1 Protein (ECD, His Tag) was purchased from Sino Biological (China), and recombinant tobacco etch virus (TEV) protease was produced and purified inhouse following standard methods. .. D ow nloaded from https://academ ic.oup.com /peds/advance-article/doi/10.1093/protein/gzag010/8655119 by guest on 18 April 2026 UN CO RR EC TE D MA NU SC RI PT Bacterial culture and library expression Escherichia coli BL21 (DE3) cells transformed with pPALU9 plasmids encoding for an affibody library (~1011 variants) were grown overnight (O/N) in Luria-Bertani (LB) medium supplemented with carbenicillin (100 μg/mL).

    Produced:

    Article Title: Engineering affibody domains as anti-idiotypic masks for nivolumab-based prodrugs
    Article Snippet: Protein concentrations were measured by absorbance at 280 nm using a spectrophotometer (Thermo Fisher, USA). .. Recombinant Human PD-1 Protein (ECD, His Tag) was purchased from Sino Biological (China), and recombinant tobacco etch virus (TEV) protease was produced and purified in-house following standard methods. .. E. coli BL21 (DE3) cells transformed with pPALU ( ) plasmids encoding for an affibody library (~10 11 variants) were grown overnight (O/N) in Luria-Bertani (LB) medium supplemented with carbenicillin (100 μg/ml).

    Article Title: Engineering affibody domains as anti-idiotypic masks for nivolumab-based prodrugs.
    Article Snippet: Protein concentrations were measured by absorbance at 280 nm using a spectrophotometer (Thermo Fisher, USA). .. Recombinant Human PD-1 Protein (ECD, His Tag) was purchased from Sino Biological (China), and recombinant tobacco etch virus (TEV) protease was produced and purified inhouse following standard methods. .. D ow nloaded from https://academ ic.oup.com /peds/advance-article/doi/10.1093/protein/gzag010/8655119 by guest on 18 April 2026 UN CO RR EC TE D MA NU SC RI PT Bacterial culture and library expression Escherichia coli BL21 (DE3) cells transformed with pPALU9 plasmids encoding for an affibody library (~1011 variants) were grown overnight (O/N) in Luria-Bertani (LB) medium supplemented with carbenicillin (100 μg/mL).

    Purification:

    Article Title: Engineering affibody domains as anti-idiotypic masks for nivolumab-based prodrugs
    Article Snippet: Protein concentrations were measured by absorbance at 280 nm using a spectrophotometer (Thermo Fisher, USA). .. Recombinant Human PD-1 Protein (ECD, His Tag) was purchased from Sino Biological (China), and recombinant tobacco etch virus (TEV) protease was produced and purified in-house following standard methods. .. E. coli BL21 (DE3) cells transformed with pPALU ( ) plasmids encoding for an affibody library (~10 11 variants) were grown overnight (O/N) in Luria-Bertani (LB) medium supplemented with carbenicillin (100 μg/ml).

    Article Title: Engineering affibody domains as anti-idiotypic masks for nivolumab-based prodrugs.
    Article Snippet: Protein concentrations were measured by absorbance at 280 nm using a spectrophotometer (Thermo Fisher, USA). .. Recombinant Human PD-1 Protein (ECD, His Tag) was purchased from Sino Biological (China), and recombinant tobacco etch virus (TEV) protease was produced and purified inhouse following standard methods. .. D ow nloaded from https://academ ic.oup.com /peds/advance-article/doi/10.1093/protein/gzag010/8655119 by guest on 18 April 2026 UN CO RR EC TE D MA NU SC RI PT Bacterial culture and library expression Escherichia coli BL21 (DE3) cells transformed with pPALU9 plasmids encoding for an affibody library (~1011 variants) were grown overnight (O/N) in Luria-Bertani (LB) medium supplemented with carbenicillin (100 μg/mL).

    Bioprocessing:

    Article Title: Tumor-Specific Delivery of Immune Checkpoint Inhibitors by Engineered AAV Vectors
    Article Snippet: .. For the detection of AAV-encoded nivolumab, plate coating was performed with 100 ng/well using recombinant human PD-1 protein (Sino Biological) in H 2 O overnight, while the remaining procedure was identical, only varying in secondary antibody concentration and incubation time (αhuFc-HRP 1:10,000 for 3 h and 1:500 for 2 h for murine αPD-1 and AAV-Nivolumab, respectively). .. Standard values were generated using the therapeutic drug Opdivo® (Bristol Myers Squibb).

    Incubation:

    Article Title: Tumor-Specific Delivery of Immune Checkpoint Inhibitors by Engineered AAV Vectors
    Article Snippet: .. For the detection of AAV-encoded nivolumab, plate coating was performed with 100 ng/well using recombinant human PD-1 protein (Sino Biological) in H 2 O overnight, while the remaining procedure was identical, only varying in secondary antibody concentration and incubation time (αhuFc-HRP 1:10,000 for 3 h and 1:500 for 2 h for murine αPD-1 and AAV-Nivolumab, respectively). .. Standard values were generated using the therapeutic drug Opdivo® (Bristol Myers Squibb).

    Functional Assay:

    Article Title: Humanized anti-PD-1 antibody and the use thereof
    Article Snippet: .. 1.4 Murine Antibody PD1-M944 Functional Assay (1) Blocking the Binding of Recombinant Human PD-1 to PD-L1: Recombinant human PD-1 protein at a concentration of 1 μg/mL was coated on a 96-well plate at 100 μL per well overnight at 4° C. The plates were washed the next day and blocked at room temperature for 1 h. 100 μL of 10 μg/mL of biotinylated protein PD-L1-Fc-biotin (SinoBiological, Inc.) was co-incubated with different concentrations (0.4 μg/mL, 2 μg/mL and 10 μg/mL) of PD1-M944 or Nivolumab (Sino Biological, Inc). ..

    Expressing:

    Article Title: PD-L1 targeted peptide demonstrates potent antitumor and immunomodulatory activity in cancer immunotherapy
    Article Snippet: .. Human PD-L1 natural ORF mammalian expression plasmid (Cat: HG10084-UT), rabbit anti-human PD-1 antibody (Clone D67, Cat: 10377-RD67), recombinant human PD-L1 protein (Cat: 10084-H08H), human PD-L1/B7-H1/CD274 protein (Cat: 10084-HNAH), biotinylated mouse PD-1/PDCD1 protein (His tag) and recombinant human PD-1 protein (Cat: 10377-H08H) were purchased from Sino Biological Inc (Beijing). .. GM-CSF (Cat: 315-03) and Murine TNF-α (Cat: 315-01A) were purchased from PEPROTECH.

    Plasmid Preparation:

    Article Title: PD-L1 targeted peptide demonstrates potent antitumor and immunomodulatory activity in cancer immunotherapy
    Article Snippet: .. Human PD-L1 natural ORF mammalian expression plasmid (Cat: HG10084-UT), rabbit anti-human PD-1 antibody (Clone D67, Cat: 10377-RD67), recombinant human PD-L1 protein (Cat: 10084-H08H), human PD-L1/B7-H1/CD274 protein (Cat: 10084-HNAH), biotinylated mouse PD-1/PDCD1 protein (His tag) and recombinant human PD-1 protein (Cat: 10377-H08H) were purchased from Sino Biological Inc (Beijing). .. GM-CSF (Cat: 315-03) and Murine TNF-α (Cat: 315-01A) were purchased from PEPROTECH.



    Similar Products

    94
    Sino Biological recombinant human pd 1 protein
    Recombinant Human Pd 1 Protein, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+pd+1+protein/Human+PD-1+Protein/pm41989091-31-0-10
    Average 94 stars, based on 1 article reviews
    recombinant human pd 1 protein - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    96
    R&D Systems human pd 1 fc chimera protein
    Human Pd 1 Fc Chimera Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+pd+1+protein/Recombinant+Human+PD-1+Fc+Chimera+Protein%2C+CF/pm41872151-167-46-52
    Average 96 stars, based on 1 article reviews
    human pd 1 fc chimera protein - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    R&D Systems pd
    Pd, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+pd+1+protein/Recombinant+Human+PD-1+Fc+Chimera+Protein%2C+CF/pm41905348-227-138-145
    Average 96 stars, based on 1 article reviews
    pd - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    93
    R&D Systems human il 2 biolegend
    Human Il 2 Biolegend, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+pd+1+protein/Recombinant+Mouse+PD-1+Fc+Chimera+Protein%2C+CF/pm41905348-227-149-145
    Average 93 stars, based on 1 article reviews
    human il 2 biolegend - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    96
    R&D Systems recombinant human pd 1 protein
    BIEXO@IPA platform for enhanced CAR-T therapy in lung cancer. In this study, iPSCs were lentivirally transduced with <t>anti-PD-1/MSLN</t> scFv to generate iPSC lines expressing the engineered construct (BiPSC). BIEXOs were isolated and concentrated from BiPSC culture supernatant via ultracentrifugation, then loaded with IPA through electroporation to form BIEXO@IPA. This platform was nebulized into orthotopic lung cancer mouse models for targeted delivery. In the lung TME, BIEXO@IPA bridges endogenous PD-1 + CD8 + T/CAR-T cells to MSLN-expressing tumor cells while blocking PD-1/PD-L1 signaling and exerting antitumor effects via : (1) BIEXO reverses tumor cell malignancy; (2) IPA delivery enhances Tpex and effector T cells (Teff); (3) activated Teff-mediated cytotoxicity
    Recombinant Human Pd 1 Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+pd+1+protein/Recombinant+Human+PD-1+Fc+Chimera+Protein%2C+CF/pmc13107855-277-0-6
    Average 96 stars, based on 1 article reviews
    recombinant human pd 1 protein - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    94
    Sino Biological h08h recombinant human pd 1 protein sino biological
    BIEXO@IPA platform for enhanced CAR-T therapy in lung cancer. In this study, iPSCs were lentivirally transduced with <t>anti-PD-1/MSLN</t> scFv to generate iPSC lines expressing the engineered construct (BiPSC). BIEXOs were isolated and concentrated from BiPSC culture supernatant via ultracentrifugation, then loaded with IPA through electroporation to form BIEXO@IPA. This platform was nebulized into orthotopic lung cancer mouse models for targeted delivery. In the lung TME, BIEXO@IPA bridges endogenous PD-1 + CD8 + T/CAR-T cells to MSLN-expressing tumor cells while blocking PD-1/PD-L1 signaling and exerting antitumor effects via : (1) BIEXO reverses tumor cell malignancy; (2) IPA delivery enhances Tpex and effector T cells (Teff); (3) activated Teff-mediated cytotoxicity
    H08h Recombinant Human Pd 1 Protein Sino Biological, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+pd+1+protein/Human+PD-1+Protein/pm41713417-256-133-138
    Average 94 stars, based on 1 article reviews
    h08h recombinant human pd 1 protein sino biological - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    95
    R&D Systems human pd 1
    BIEXO@IPA platform for enhanced CAR-T therapy in lung cancer. In this study, iPSCs were lentivirally transduced with <t>anti-PD-1/MSLN</t> scFv to generate iPSC lines expressing the engineered construct (BiPSC). BIEXOs were isolated and concentrated from BiPSC culture supernatant via ultracentrifugation, then loaded with IPA through electroporation to form BIEXO@IPA. This platform was nebulized into orthotopic lung cancer mouse models for targeted delivery. In the lung TME, BIEXO@IPA bridges endogenous PD-1 + CD8 + T/CAR-T cells to MSLN-expressing tumor cells while blocking PD-1/PD-L1 signaling and exerting antitumor effects via : (1) BIEXO reverses tumor cell malignancy; (2) IPA delivery enhances Tpex and effector T cells (Teff); (3) activated Teff-mediated cytotoxicity
    Human Pd 1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+pd+1+protein/Recombinant+Human+PD-1+His+Tagged+Protein%2C+CF/us12540185-1219-4-10
    Average 95 stars, based on 1 article reviews
    human pd 1 - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    R&D Systems human pd
    BIEXO@IPA platform for enhanced CAR-T therapy in lung cancer. In this study, iPSCs were lentivirally transduced with <t>anti-PD-1/MSLN</t> scFv to generate iPSC lines expressing the engineered construct (BiPSC). BIEXOs were isolated and concentrated from BiPSC culture supernatant via ultracentrifugation, then loaded with IPA through electroporation to form BIEXO@IPA. This platform was nebulized into orthotopic lung cancer mouse models for targeted delivery. In the lung TME, BIEXO@IPA bridges endogenous PD-1 + CD8 + T/CAR-T cells to MSLN-expressing tumor cells while blocking PD-1/PD-L1 signaling and exerting antitumor effects via : (1) BIEXO reverses tumor cell malignancy; (2) IPA delivery enhances Tpex and effector T cells (Teff); (3) activated Teff-mediated cytotoxicity
    Human Pd, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+pd+1+protein/Recombinant+Human+PD-1+His+Tagged+Protein%2C+CF/pm41650586-82-4-9
    Average 95 stars, based on 1 article reviews
    human pd - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    Image Search Results


    BIEXO@IPA platform for enhanced CAR-T therapy in lung cancer. In this study, iPSCs were lentivirally transduced with anti-PD-1/MSLN scFv to generate iPSC lines expressing the engineered construct (BiPSC). BIEXOs were isolated and concentrated from BiPSC culture supernatant via ultracentrifugation, then loaded with IPA through electroporation to form BIEXO@IPA. This platform was nebulized into orthotopic lung cancer mouse models for targeted delivery. In the lung TME, BIEXO@IPA bridges endogenous PD-1 + CD8 + T/CAR-T cells to MSLN-expressing tumor cells while blocking PD-1/PD-L1 signaling and exerting antitumor effects via : (1) BIEXO reverses tumor cell malignancy; (2) IPA delivery enhances Tpex and effector T cells (Teff); (3) activated Teff-mediated cytotoxicity

    Journal: Journal of Nanobiotechnology

    Article Title: Engineering BiTE-inspired IPSC-exosomes to potentiate CAR-T cell therapy against lung cancer

    doi: 10.1186/s12951-026-04242-3

    Figure Lengend Snippet: BIEXO@IPA platform for enhanced CAR-T therapy in lung cancer. In this study, iPSCs were lentivirally transduced with anti-PD-1/MSLN scFv to generate iPSC lines expressing the engineered construct (BiPSC). BIEXOs were isolated and concentrated from BiPSC culture supernatant via ultracentrifugation, then loaded with IPA through electroporation to form BIEXO@IPA. This platform was nebulized into orthotopic lung cancer mouse models for targeted delivery. In the lung TME, BIEXO@IPA bridges endogenous PD-1 + CD8 + T/CAR-T cells to MSLN-expressing tumor cells while blocking PD-1/PD-L1 signaling and exerting antitumor effects via : (1) BIEXO reverses tumor cell malignancy; (2) IPA delivery enhances Tpex and effector T cells (Teff); (3) activated Teff-mediated cytotoxicity

    Article Snippet: Recombinant human PD-1 protein (5 μg/mL, R&D Systems, 1086-PD) was used for capture.

    Techniques: Transduction, Expressing, Construct, Isolation, Electroporation, Blocking Assay

    Functional characterization and T-cell bridging activity. ( a , b ) Binding affinity analysis of engineered exosomes (MIEXO, PIEXO, BIEXO) to MSLN (a) and PD-1 ( b ) via indirect ELISA. Exosomes were added to PD-1 or MSLN-coated plates and detected via an HRP-conjugated anti-His-tag antibody. ( c , d ) Flow cytometric analysis of engineered exosomes (100 µg/mL) binding to PD-1 + T cells ( c ) and LLC-MSLN cells ( d ), with His-tag mean fluorescence intensity (MFI) quantification (right panel). ( e , f ) Confocal microscopy analysis of BIEXO targeting to PD-1 + T cells ( e ) and LLC-MSLN cells ( f ). ( g ) Representative confocal microscopy images and corresponding quantification showing BIEXO-mediated bridging between PD-1 + T cells and LLC-MSLN cells. ( h ) FRET analysis of dose-dependent bridging efficiency. ( i , j ) Prevention of PD-L1-induced T-cell exhaustion measured by LDH release ( n = 3). ( k , l ) Experimental design (k) for ex vivo culture of CD8 + T cells isolated from mouse spleen, and flow cytometric analysis of TCF-1 + Tpex cell expansion in PD-1 + CD8 + T cells following pre-treatment with the AhR antagonist CH-223,191 and BIEXO@IPA stimulation ( l ). ( m ) In vitro growth inhibition of LLC-MSLN cells following treatment. ( n ) Enhanced cytotoxicity of TILs isolated from LLC-MSLN tumor-bearing mice against LLC-MSLN cells following BIEXO@IPA treatment. Data are presented as mean ± SD. Statistical significance was determined using one-way ANOVA followed by Tukey’s multiple comparisons test (c, d, j, m, n). * p < 0.05 , ** p < 0.01 , *** p < 0.001 , **** p < 0.0001

    Journal: Journal of Nanobiotechnology

    Article Title: Engineering BiTE-inspired IPSC-exosomes to potentiate CAR-T cell therapy against lung cancer

    doi: 10.1186/s12951-026-04242-3

    Figure Lengend Snippet: Functional characterization and T-cell bridging activity. ( a , b ) Binding affinity analysis of engineered exosomes (MIEXO, PIEXO, BIEXO) to MSLN (a) and PD-1 ( b ) via indirect ELISA. Exosomes were added to PD-1 or MSLN-coated plates and detected via an HRP-conjugated anti-His-tag antibody. ( c , d ) Flow cytometric analysis of engineered exosomes (100 µg/mL) binding to PD-1 + T cells ( c ) and LLC-MSLN cells ( d ), with His-tag mean fluorescence intensity (MFI) quantification (right panel). ( e , f ) Confocal microscopy analysis of BIEXO targeting to PD-1 + T cells ( e ) and LLC-MSLN cells ( f ). ( g ) Representative confocal microscopy images and corresponding quantification showing BIEXO-mediated bridging between PD-1 + T cells and LLC-MSLN cells. ( h ) FRET analysis of dose-dependent bridging efficiency. ( i , j ) Prevention of PD-L1-induced T-cell exhaustion measured by LDH release ( n = 3). ( k , l ) Experimental design (k) for ex vivo culture of CD8 + T cells isolated from mouse spleen, and flow cytometric analysis of TCF-1 + Tpex cell expansion in PD-1 + CD8 + T cells following pre-treatment with the AhR antagonist CH-223,191 and BIEXO@IPA stimulation ( l ). ( m ) In vitro growth inhibition of LLC-MSLN cells following treatment. ( n ) Enhanced cytotoxicity of TILs isolated from LLC-MSLN tumor-bearing mice against LLC-MSLN cells following BIEXO@IPA treatment. Data are presented as mean ± SD. Statistical significance was determined using one-way ANOVA followed by Tukey’s multiple comparisons test (c, d, j, m, n). * p < 0.05 , ** p < 0.01 , *** p < 0.001 , **** p < 0.0001

    Article Snippet: Recombinant human PD-1 protein (5 μg/mL, R&D Systems, 1086-PD) was used for capture.

    Techniques: Functional Assay, Activity Assay, Binding Assay, Indirect ELISA, Fluorescence, Confocal Microscopy, Ex Vivo, Isolation, In Vitro, Inhibition